Navigation Links
Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
Date:11/4/2009

cialty pharmaceuticals. Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System for transdermal drug delivery of a wide range of novel topical reformulations of widely-used, FDA-approved products.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's ongoing studies, including the efficacy of Echo's Symphony tCGM System, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM System, Echo's ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo's ability to develop, market and sell diagnostic and transdermal drug delivery products based on its skin permeation platform technologies, including the Symphony tCGM System, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its Symphony tCGM System. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K for the year ended December 31, 2008, its quarterly reports on Form
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor
2. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
3. Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
4. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
5. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
6. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum
7. Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders
8. Logical Therapeutics to Present Data on LT-NS001 at American College of Gastroenterology Annual Meeting
9. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
10. Oxygen Biotherapeutics, Inc. to Webcast Shareholder Meeting
11. ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... VIEJO , Kalifornien, 20. Mai 2013 ... bekannt, dass das Unternehmen die CE-Kennzeichnung für ... zur Embolisation von Aneurysmen erhalten hat. Das ... Europa bereits mit der kontrollierten Einführung dieser ... bietet die SL-Produktfamilie auch ein verbessertes Handling, ...
(Date:5/20/2013)... LONDON , BERLIN ... 2013 Arthroscopy Devices Market ... Preference for Minimally Invasive Procedures to Drive Future Growth" ... trends for the six arthroscopy device market segments: arthroscopes, ... arthroscopy radio frequency systems, and arthroscopy visualization systems. The ...
(Date:5/20/2013)... 2013  Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4
(Date:5/20/2013)... Wolters Kluwer Health is pleased to ... published journals won 13 ASHPE awards in 10 ... and publications for editorial, design, print and online ... be recognized year after year for delivering high-quality ... with quality, depth, and impact," said Jayne Marks, ...
(Date:5/20/2013)... May 20, 2013 Join Seva Foundation in ... at the Palace of Fine Arts Theater in ... , C.C. White and Shimshai, with host Wavy Gravy. All ... world. , Reserved seats are $40 & $55, ... the artists and a front row seat at the show. ...
(Date:5/20/2013)... HealthEconomics.Com , the global leader ... present a new breakthrough in digital marketing and communications ... the reach of traditional, real-world trade shows and conferences ... feel, and benefits of a physical trade show, but ... hours a day, seven days a week, and three ...
(Date:5/20/2013)... 2013 A new Benefits of Pharmacy ... the creators of the MedEx Pack announced. ... Pharmacy Home Delivery, in order to provide useful details for ... handled. Clyde Furuta, MedEx Direct owner and pharmacist said, ... that with a product like the MedEx Pack, patients can ...
(Date:5/20/2013)... Fresno, CA (PRWEB) May 20, 2013 It’s ... a chance, there’s still time to bust out those dusty ... going to have a little cross-company challenge in the office ... to see who can log the most pledged miles for ... building, but they’ll never share their miles! , *insert battle ...
Breaking Medicine News(10 mins):Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2Health News:Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy,May 27th 7:00 PM 2Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 2Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 3Health News:Benefits of Pharmacy Home Delivery Report Published by MedEx Direct 2
... Quad Will Become the Highest-Selling Antiretroviral in the ... from Decision ResourcesWALTHAM, Mass., May 19 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... six percent annual growth in the HIV drug ...
... ( www.apieron.com ) significantly strengthened its senior ... Vice President, Sales & Marketing, and Bryan Miller as ... Bubrick has more than 20 years of operational and ... in diabetes management. Prior to joining Apieron, Mr. Bubrick ...
... May 19 New Life Agency filed suit against ... contract.This lawsuit grew out of a previous contractual relationship ... in December 2005. Once New Life Agency assumed direct ... for New Life,s Surrogate Maternity and Cycle Medical Plan(R), ...
... Has 6 Front Range LocationsDENVER, May 19 Clinic ... Solutions, announced today the firm has secured an agreement ... to all Front Range MedExpress Urgent Care locations. ... nationwide reach."This is a key new contract for us," ...
... INTERESTS ARE NOT ALIGNED WITH STOCKHOLDERSADVOCAT BOARD NEEDS TO ... May 19 Bristol Investment Fund, Ltd. ("Bristol") announced ... stockholders of Advocat, Inc. (the "Company") (Nasdaq: ... qualified and independent director nominees, Paul Kessler and Richard ...
... be Issued from Among Intradigm,s Large Collection of ... Intradigm Corporation, a leading developer of targeted, ... issuance of United States patent 7,534,878, titled "Composition ... Cancer and Other Neovascularization Diseases." The issued ...
Cached Medicine News:Health News:Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013 2Health News:Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013 3Health News:Apieron Strengthens Senior Leadership With Commercial, Financial Appointments 2Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 2Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 3Health News:Clinic Service Announces Agreement to Provide Billing Service to MedExpress 2Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 2Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 3Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 4Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 5Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 6Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 7Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 8Health News:Support Bristol's Highly Qualified Independent Nominees for Advocat Board 9Health News:Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 2Health News:Intradigm Announces Issuance of RNA Interference (RNAi) Patent Covering Potent siRNA Sequence 3
... Eppendorf Mastercycler Family offers fast temperature control, ... optimal flexibility. Personal cards enable safe program ... transfer of individual protocols between different Mastercyclers. ... PCR and come with a two-year warranty. ...
... The latest addition to ... thermal cyclers is the personal-sized ... ideal instrument for both basic ... It represents the culmination of ...
... well thermocycler with unique High ... for fastest available heating and ... with High Pressure Lid for ... Includes motorized lid for ...
... highest precision, more user-friendliness and absolute reliability ... the definition of the Mastercycler ep system. ... research has been developing dynamically. The same ... Systems. To keep pace with these ...
Medicine Products: